Siyi Chen

No.1 Panfu Road
Guangzhou, 510180, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Localized Intra- and Inter-Tumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer.

Localized Intra- and Inter-Tumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer.

Journal: IEEE journal of biomedical and health informatics

Published: December 24, 2025

Machine Learning Model Based on Multiparametric MRI for Distinguishing HER2 Expression Level in Breast Cancer.

Machine Learning Model Based on Multiparametric MRI for Distinguishing HER2 Expression Level in Breast Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: October 14, 2025

XRadNet: A Radiomics-Guided Breast Cancer Molecular Subtype Prediction Network With a Radiomics Explanation.

XRadNet: A Radiomics-Guided Breast Cancer Molecular Subtype Prediction Network With a Radiomics Explanation.

Journal: IEEE journal of biomedical and health informatics

Published: March 17, 2025

Development and validation of an MRI spatiotemporal interaction model for early noninvasive prediction of neoadjuvant chemotherapy response in breast cancer: a multicentre study.

Development and validation of an MRI spatiotemporal interaction model for early noninvasive prediction of neoadjuvant chemotherapy response in breast cancer: a multicentre study.

Journal: EClinicalMedicine

Published: February 18, 2025

The Role of Multiparametric MRI Radiomics for Preoperative Prediction of Axillary Lymph Node Metastasis in Patients With Invasive Breast Cancer: A Comparative Study.

The Role of Multiparametric MRI Radiomics for Preoperative Prediction of Axillary Lymph Node Metastasis in Patients With Invasive Breast Cancer: A Comparative Study.

Journal: Cancer innovation

Published: October 21, 2024

Multiparametric MRI Radiomics With Machine Learning for Differentiating HER2-Zero, -Low, and -Positive Breast Cancer: Model Development, Testing, and Interpretability Analysis.

Multiparametric MRI Radiomics With Machine Learning for Differentiating HER2-Zero, -Low, and -Positive Breast Cancer: Model Development, Testing, and Interpretability Analysis.

Journal: AJR. American journal of roentgenology

Published: October 16, 2024

Self-assembled metal-phenolic network nanoparticles for delivery of a cisplatin prodrug for synergistic chemo-immunotherapy.

Self-assembled metal-phenolic network nanoparticles for delivery of a cisplatin prodrug for synergistic chemo-immunotherapy.

Journal: Biomaterials science

Published: June 10, 2024

The longitudinal changes in multiparametric MRI during neoadjuvant chemotherapy can predict treatment response early in patients with HER2-positive breast cancer.

The longitudinal changes in multiparametric MRI during neoadjuvant chemotherapy can predict treatment response early in patients with HER2-positive breast cancer.

Journal: European journal of radiology

Published: December 05, 2023

Noninvasive identification of HER2-low-positive status by MRI-based deep learning radiomics predicts the disease-free survival of patients with breast cancer.

Noninvasive identification of HER2-low-positive status by MRI-based deep learning radiomics predicts the disease-free survival of patients with breast cancer.

Journal: European radiology

Published: August 21, 2022

PMSM sensorless control with separate control strategies and smooth switch from low speed to high speed.

PMSM sensorless control with separate control strategies and smooth switch from low speed to high speed.

Journal: ISA transactions

Published: November 25, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026